Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular LithotripsyGlobeNewsWire • 05/23/22
Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two YearsGlobeNewsWire • 05/19/22
Shockwave IVL Coronary Studies Demonstrate Excellent PCI Outcomes in Both Women and Men at One YearGlobeNewsWire • 05/19/22
ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Shockwave Medical (SWAV) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/09/22
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor ConferencesGlobeNewsWire • 04/27/22
Shockwave Medical's (SWAV) New Launch to Lower IVL Treatment TimeZacks Investment Research • 04/05/22
Shockwave Medical Announces Global Launch of New Peripheral Intravascular Lithotripsy CatheterGlobeNewsWire • 03/31/22
Shockwave Medical (SWAV) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 03/17/22
ShockWave Medical's (SWAV) CEO Doug Godshall on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/18/22
Shockwave Medical Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/17/22
Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare ConferenceGlobeNewsWire • 02/04/22